U.S. Capital Wealth Advisors LLC Purchases 706 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

U.S. Capital Wealth Advisors LLC lifted its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 53.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,032 shares of the biotechnology company’s stock after buying an additional 706 shares during the quarter. U.S. Capital Wealth Advisors LLC’s holdings in Axon Enterprise were worth $1,208,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. New Wave Wealth Advisors LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at $40,000. Prestige Wealth Management Group LLC grew its stake in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 44 shares in the last quarter. Versant Capital Management Inc lifted its holdings in Axon Enterprise by 4,750.0% during the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company’s stock valued at $58,000 after purchasing an additional 95 shares during the last quarter. Berbice Capital Management LLC acquired a new stake in Axon Enterprise during the 4th quarter valued at $59,000. Finally, Brooklyn Investment Group acquired a new stake in Axon Enterprise during the 3rd quarter valued at $41,000. 79.08% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have issued reports on AXON shares. TD Cowen started coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. Needham & Company LLC raised their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. JMP Securities raised their price target on Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a report on Tuesday. Finally, Robert W. Baird lifted their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and an average target price of $542.15.

Axon Enterprise Stock Up 0.7 %

AXON stock opened at $662.91 on Wednesday. The company has a market cap of $50.55 billion, a PE ratio of 171.30, a price-to-earnings-growth ratio of 6.54 and a beta of 1.05. The business has a 50-day simple moving average of $621.03 and a 200 day simple moving average of $488.66. Axon Enterprise, Inc. has a 52 week low of $252.20 and a 52 week high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now owns 2,392 shares in the company, valued at $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 50,545 shares of company stock valued at $30,721,337 over the last quarter. 5.70% of the stock is owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.